Study Eases Concern That Common Diabetes Med, Canagliflozin (Invokana, Invokamet), Might Harm Bones

THURSDAY, Jan. 3, 2019 — If you have type 2 diabetes and you’re taking canagliflozin to help control your blood sugar, a new study has some good news for you: The drug doesn’t appear to raise the risk of bone fractures.
Previously, research had…